These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33052913)

  • 1. Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype.
    Chelebian E; Fuster-Garcia E; Álvarez-Torres MDM; Juan-Albarracín J; García-Gómez JM
    PLoS One; 2020; 15(10):e0232500. PubMed ID: 33052913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma: Vascular Habitats Detected at Preoperative Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Survival.
    Juan-Albarracín J; Fuster-Garcia E; Pérez-Girbés A; Aparici-Robles F; Alberich-Bayarri Á; Revert-Ventura A; Martí-Bonmatí L; García-Gómez JM
    Radiology; 2018 Jun; 287(3):944-954. PubMed ID: 29357274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study.
    Del Mar Álvarez-Torres M; Juan-Albarracín J; Fuster-Garcia E; Bellvís-Bataller F; Lorente D; Reynés G; Font de Mora J; Aparici-Robles F; Botella C; Muñoz-Langa J; Faubel R; Asensio-Cuesta S; García-Ferrando GA; Chelebian E; Auger C; Pineda J; Rovira A; Oleaga L; Mollà-Olmos E; Revert AJ; Tshibanda L; Crisi G; Emblem KE; Martin D; Due-Tønnessen P; Meling TR; Filice S; Sáez C; García-Gómez JM
    J Magn Reson Imaging; 2020 May; 51(5):1478-1486. PubMed ID: 31654541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
    Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
    J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
    Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
    Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
    J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
    Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R
    Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
    Chaddad A; Desrosiers C; Hassan L; Tanougast C
    Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular architecture mapping for early detection of glioblastoma recurrence.
    Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
    Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of
    Rathore S; Akbari H; Bakas S; Pisapia JM; Shukla G; Rudie JD; Da X; Davuluri RV; Dahmane N; O'Rourke DM; Davatzikos C
    Front Comput Neurosci; 2019; 13():81. PubMed ID: 31920606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
    Chaddad A; Sabri S; Niazi T; Abdulkarim B
    Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.
    Gutman DA; Cooper LA; Hwang SN; Holder CA; Gao J; Aurora TD; Dunn WD; Scarpace L; Mikkelsen T; Jain R; Wintermark M; Jilwan M; Raghavan P; Huang E; Clifford RJ; Mongkolwat P; Kleper V; Freymann J; Kirby J; Zinn PO; Moreno CS; Jaffe C; Colen R; Rubin DL; Saltz J; Flanders A; Brat DJ
    Radiology; 2013 May; 267(2):560-9. PubMed ID: 23392431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma.
    Park JE; Kim HS; Park SY; Nam SJ; Chun SM; Jo Y; Kim JH
    Radiology; 2020 Feb; 294(2):388-397. PubMed ID: 31845844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?
    Soike MH; McTyre ER; Shah N; Puchalski RB; Holmes JA; Paulsson AK; Miller LD; Cramer CK; Lesser GJ; Strowd RE; Hinson WH; Mott RT; Johnson AJ; Lo HW; Laxton AW; Tatter SB; Debinski W; Chan MD
    Neuroradiology; 2018 Oct; 60(10):1043-1051. PubMed ID: 30094640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative MRI for analysis of peritumoral edema in malignant gliomas.
    Blystad I; Warntjes JBM; Smedby Ö; Lundberg P; Larsson EM; Tisell A
    PLoS One; 2017; 12(5):e0177135. PubMed ID: 28542553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive O
    Hajianfar G; Shiri I; Maleki H; Oveisi N; Haghparast A; Abdollahi H; Oveisi M
    World Neurosurg; 2019 Dec; 132():e140-e161. PubMed ID: 31505292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma.
    Sharma A; Bendre A; Mondal A; Muzumdar D; Goel N; Shiras A
    Front Oncol; 2017; 7():146. PubMed ID: 28744448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The wavelet power spectrum of perfusion weighted MRI correlates with tumor vascularity in biopsy-proven glioblastoma samples.
    Rotkopf LT; Wiestler B; Preibisch C; Liesche-Starnecker F; Pyka T; Nörenberg D; Bette S; Gempt J; Thierfelder KM; Zimmer C; Huber T
    PLoS One; 2020; 15(1):e0228030. PubMed ID: 31971966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1.
    Rathore S; Akbari H; Rozycki M; Abdullah KG; Nasrallah MP; Binder ZA; Davuluri RV; Lustig RA; Dahmane N; Bilello M; O'Rourke DM; Davatzikos C
    Sci Rep; 2018 Mar; 8(1):5087. PubMed ID: 29572492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.